EVAX
Price
$0.80
Change
+$0.01 (+1.27%)
Updated
Nov 30, 6:59 PM EST
123 days until earnings call
PROK
Price
$1.69
Change
-$0.00 (-0.00%)
Updated
Nov 30, 3:59 PM EST
116 days until earnings call
Ad is loading...

Compare trend and price EVAX vs PROK

Header iconEVAX vs PROK Comparison
Open Charts EVAX vs PROKBanner chart's image
Evaxion Biotech A/S American Depositary Share
Price$0.80
Change+$0.01 (+1.27%)
Volume$166.36K
CapitalizationN/A
ProKidney
Price$1.69
Change-$0.00 (-0.00%)
Volume$3.04K
CapitalizationN/A
View a ticker or compare two or three
EVAX vs PROK Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
EVAX vs. PROK commentary
Dec 01, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a Hold and PROK is a Buy.

COMPARISON
Comparison
Dec 01, 2023
Stock price -- (EVAX: $0.80 vs. PROK: $1.68)
Brand notoriety: EVAX and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 300% vs. PROK: 65%
Market capitalization -- EVAX: $22.61M vs. PROK: $116.82M
EVAX [@Biotechnology] is valued at $22.61M. PROK’s [@Biotechnology] market capitalization is $116.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • EVAX’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, PROK is a better buy in the long-term than EVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 2 TA indicator(s) are bullish while PROK’s TA Score has 5 bullish TA indicator(s).

  • EVAX’s TA Score: 2 bullish, 7 bearish.
  • PROK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PROK is a better buy in the short-term than EVAX.

Price Growth

EVAX (@Biotechnology) experienced а -0.12% price change this week, while PROK (@Biotechnology) price change was -5.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.54%. For the same industry, the average monthly price growth was +27.11%, and the average quarterly price growth was +23.26%.

Reported Earning Dates

EVAX is expected to report earnings on Apr 02, 2024.

PROK is expected to report earnings on Mar 26, 2024.

Industries' Descriptions

@Biotechnology (+2.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for EVAX with price predictions.
OPEN
A.I.dvisor published
a Summary for PROK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PROK($117M) has a higher market cap than EVAX($22.6M). EVAX YTD gains are higher at: -54.986 vs. PROK (-75.437). EVAX has higher annual earnings (EBITDA): -24.28M vs. PROK (-132.84M). PROK has more cash in the bank: 396M vs. EVAX (7.12M). PROK has less debt than EVAX: PROK (2.79M) vs EVAX (10.5M). EVAX (0) and PROK (0) have equivalent revenues.
EVAXPROKEVAX / PROK
Capitalization22.6M117M19%
EBITDA-24.28M-132.84M18%
Gain YTD-54.986-75.43773%
P/E RatioN/AN/A-
Revenue00-
Total Cash7.12M396M2%
Total Debt10.5M2.79M377%
TECHNICAL ANALYSIS
Technical Analysis
EVAXPROK
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
42%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
61%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
42%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
51%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
55%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 3 days ago
63%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 8 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
56%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
54%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVAV137.612.82
+2.09%
AeroVironment
ESEA29.460.47
+1.62%
Euroseas Ltd
TMST20.320.16
+0.79%
TIMKENSTEEL Corp
CVE17.760.11
+0.62%
Cenovus Energy
JT1.02N/A
N/A
Jianpu Technology

EVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVAX has been loosely correlated with ATRA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if EVAX jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
+2.44%
ATRA - EVAX
40%
Loosely correlated
-4.77%
IKNA - EVAX
28%
Poorly correlated
+3.57%
NRIX - EVAX
27%
Poorly correlated
+1.47%
SPRB - EVAX
27%
Poorly correlated
+2.92%
ORMP - EVAX
25%
Poorly correlated
+0.91%
More

PROK and

Correlation & Price change

A.I.dvisor tells us that PROK and FBIO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROK and FBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-9.89%
FBIO - PROK
30%
Poorly correlated
-2.44%
CRSP - PROK
29%
Poorly correlated
-3.42%
PNT - PROK
28%
Poorly correlated
-0.37%
AGEN - PROK
28%
Poorly correlated
+10.29%
CMPX - PROK
27%
Poorly correlated
-4.07%
More